What are Twist Bioscience Corporation's total assets?

Twist Bioscience Corporation (TWST) holds $676.2M in total assets, up 13.5% year over year.

How much debt does Twist Bioscience Corporation have?

Twist Bioscience Corporation carries $110.8M in total debt against $455.1M of shareholders' equity, a debt-to-equity ratio of 0.24.

How much cash does Twist Bioscience Corporation have?

Twist Bioscience Corporation holds $124.9M in cash and equivalents.

Can Twist Bioscience Corporation cover its short-term obligations?

Its current ratio is 2.70 — current assets exceed current liabilities.

Where does Twist Bioscience Corporation's balance sheet data come from?

Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Twist Bioscience Corporation TWST Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$185.43M-19.1%	$229.13M-20.8%	$289.28M-23.9%	$380.26M-18.6%
Short-term investments	$49.39M-1.4%	$50.08M+0.3%	$49.94M-60.5%	$126.28M+949%
Restricted cash	$2.38M-15.6%	$2.82M+0.2%	$2.81M+78.8%	$1.57M+2.7%
Accounts receivable, net	$57.02M+63.4%	$34.9M-20.8%	$44.06M+23.4%	$35.71M+34.5%
Inventories	$28.31M+17.6%	$24.08M-24.9%	$32.06M-18.4%	$39.31M+23.6%
Raw materials	$20.19M+16.6%	$17.32M-35.9%	$27.02M-6.1%	$28.79M+53.3%
Work in process	$2.27M+5.5%	$2.15M+92.8%	$1.11M+1,013%	$100K-94.7%
Finished goods	$5.85M+26.8%	$4.62M+17.6%	$3.93M-48.7%	$7.65M-6.5%
Prepaid expenses and other current assets	$15.2M+33.4%	$11.4M-2.7%	$11.72M-1.7%	$11.91M+43.8%
Total current assets	$332.97M-4.0%	$346.78M-18.3%	$424.26M-28.9%	$596.48M+9.1%
Property and equipment, net	$102.28M-0.2%	$102.52M-22.2%	$131.83M-5.5%	$139.44M+216%
Accumulated depreciation	$94.99M+25.6%	$75.64M+49.3%	$50.66M+59.4%	$31.78M+2,223%
Operating lease right-of-use assets	4,937,700,000%-945,200,000%	5,882,900,000%-1,270,200,000%	7,153,100,000%-341,700,000%	7,494,800,000%+1,336,800,000%
Goodwill	$82.2M-4.2%	$85.81M0.0%	$85.81M0.0%	$85.81M+283%
Intangible assets, net	$13.43M-7.3%	$14.48M-73.4%	$54.48M-8.8%	$59.74M+227%
Other non-current assets	$4.9M+213%	$1.57M-72.4%	$5.68M+67.8%	$3.39M-55.9%
Total investments	$54.34M+3,463%	$1.53M—	——	——
Total assets	$641.86M+4.5%	$614.32M-20.9%	$776.4M-19.2%	$961.38M+36.9%
Accounts payable	$11.09M+581%	$1.63M-88.4%	$14.05M-30.1%	$20.09M+34.8%
Accrued expenses	$31.29M-7.0%	$33.65M+30.3%	$25.82M-4.5%	$27.02M+21.0%
Deferred revenue	——	——	——	$3.48M—
Operating lease liabilities, current	$13.82M-6.6%	$14.81M-0.6%	$14.9M+9.2%	$13.64M+66.1%
Contract liabilities	$6.88M+223%	$2.13M-29.0%	$3M-14.3%	$3.5M—
Income taxes payable	$4.54M+66.7%	$2.73M-37.7%	$4.37M+19.5%	$3.66M+50.0%
Total current liabilities	$91.41M+28.7%	$71.01M-3.2%	$73.32M-19.1%	$90.66M+43.8%
Long-term debt	$15M—	$0—	——	——
Operating lease liabilities, non-current	$61.75M-12.1%	$70.22M-11.3%	$79.17M-2.6%	$81.27M+52.9%
Operating Lease Liabilities (Total)	$75.57M-11.1%	$85.03M—	——	——
Other non-current liabilities	$747K+83.5%	$407K-14.3%	$475K+692%	$60K-98.8%
Total liabilities	$168.9M+19.3%	$141.63M—	$0-100%	$11.69M+18.6%
Common stock	200M—	0—	0—	0—
Additional paid-in capital	$1.79B+4.6%	$1.72B+3.5%	$1.66B+2.3%	$1.62B+36.0%
Retained earnings	-$1.32B-6.3%	-$1.24B-20.2%	-$1.03B-24.7%	-$828.42M-35.7%
Accumulated other comprehensive income (loss)	-$627K-20.1%	-$522K+31.0%	-$756K+59.0%	-$1.84M-438%
Total stockholders' equity	$472.96M+0.1%	$472.69M-24.2%	$623.43M-21.0%	$789.39M+35.9%
Total liabilities and stockholders' equity	$641.86M+4.5%	$614.32M-20.9%	$776.4M-19.2%	$961.38M+36.9%
Available-for-Sale Debt Securities - Amortized Cost	$49.32M-1.3%	$49.96M—	——	——
Allowance for Doubtful Accounts	$600K-14.3%	$700K—	——	$234K-30.6%
Allowance for Doubtful Accounts Receivable (Current)	$600K-14.3%	$700K—	——	$234K-30.6%
Cash, Cash Equivalents, and Marketable Securities	$49.39M-1.4%	$50.08M—	——	——
Other current assets	$1.72M—	——	——	——
Operating Lease Income - 2022 (Lessor)	——	——	——	——
Operating Lease Income - 2025 (Lessor)	——	——	——	——
Operating Lease Receivables (Current)	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$4.9M+213%	$1.57M-72.4%	$5.68M+67.8%	$3.39M-55.9%
Equity Securities (FV-NI) - Non-Current	$54.34M+3,463%	$1.53M—	——	——
Equity Securities (Non-Current)	$54.34M+3,463%	$1.53M—	——	——
Finite Lived Intangible Assets - Gross	$17.9M-72.9%	$66.13M0.0%	$66.13M0.0%	$66.13M+237%
Investments - Amortized Cost Basis	$54.3M+8.7%	$49.96M—	——	——
Net Investment in Lease	$49.38M-16.1%	$58.83M-17.8%	$71.53M-4.6%	$74.95M+21.7%
Intangible assets — net	$13.43M-7.3%	$14.48M-73.4%	$54.48M-8.8%	$59.74M+227%
Operating lease right-of-use assets	$49.38M-16.1%	$58.83M-17.8%	$71.53M-4.6%	$74.95M+21.7%
Other non-current assets	$4.9M+213%	$1.57M-72.4%	$5.68M+67.8%	$3.39M-55.9%
Property, plant and equipment at cost	$197.28M+10.7%	$178.16M-2.4%	$182.49M+6.6%	$171.22M—
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$49.39M-1.4%	$50.08M+0.3%	$49.94M-60.5%	$126.28M+949%
Operating Lease Income - 2026 (Lessor)	——	——	——	——
Operating Lease Income - 2027 (Lessor)	——	——	——	——
Operating Lease Income - 2028 (Lessor)	——	——	——	——
Operating Lease Income - 2029 (Lessor)	——	——	——	——
Operating Lease Income - Thereafter (Lessor)	——	——	——	——
Operating Lease Right-of-Use Assets in Other Assets	$49.38M-16.1%	$58.83M-17.8%	$71.53M-4.6%	$74.95M+21.7%
Software and Technology Licenses, Net	$4.9M+213%	$1.57M-72.4%	$5.68M+67.8%	$3.39M-55.9%
Accrued Litigation	$229K—	——	——	——
Accrued Manufacturing Costs	$31.29M-7.0%	$33.65M+30.3%	$25.82M-4.5%	$27.02M+21.0%
Other Commercial Liabilities	$22.82M+51.1%	$15.1M+40.5%	$10.75M+5.8%	$10.17M+58.0%
Accrued Liabilities, Current	$22.82M+51.1%	$15.1M+40.5%	$10.75M+5.8%	$10.17M+58.0%
Deferred income	$6.88M+223%	$2.13M-28.9%	$3M-13.7%	$3.48M—
Compensation and benefits	$31.29M-7.0%	$33.65M+30.3%	$25.82M-4.5%	$27.02M+21.0%
Other accrued liabilities	$35.2M+505%	$5.82M-25.5%	$7.8M-60.5%	$19.74M+105%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Lease Liability Payments - 2021	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Settlement Liabilities (Current)	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	——	——	——
Lease Liability Payments - Due After Year Five	——	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	——	——	——
Accrued litigation	$229K—	——	——	——
Other Debt Including Capitalized Leases	$15M—	$0—	——	——
Total debt	$90.57M+6.5%	$85.03M-9.6%	$94.07M-0.9%	$94.91M+50.8%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	60.6M+3.0%	58.9M+2.3%	57.6M+1.8%	56.5M+14.2%
Common Stock Shares Outstanding	$6.62M-82.5%	$37.84M+464%	$6.72M-79.9%	$33.45M-86.2%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Share-Based Payment Award Options Outstanding - Number	1.3M-32.6%	1.9M-10.7%	2.1M-13.6%	2.5M-14.7%
Shares Reserved for Future Issuance Under Stock Plans	716K+17.2%	611K+13.4%	539K+6.3%	507K+42.8%
Unrealized Gains on Investments	$69K-42.0%	$119K—	$0—	$0—
Unrealized Losses on Investments (Before Tax)	$0—	$0-100%	$86K-94.6%	$1.59M—
Weighted Average Exercise Price of Outstanding Options	$30.80+4.1%	$29.60+22.4%	$24.18-2.0%	$24.67+8.1%
Cumulative Cost Basis	$49.32M-1.3%	$49.96M+1,246%	$3.71M-97.8%	$171.22M—
Operating Lease Income - 2023 (Lessor)	——	——	——	——
Operating Lease Income - 2024 (Lessor)	——	——	——	——
Accounts Receivable, Allowance for Credit Loss	$600K-14.3%	$700K—	——	$234K-30.6%
Asset acquisition purchase consideration	$0—	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$0—	$0-100%	$86K-94.6%	$1.59M—
Gross Unrealized Gains	$69K-42.0%	$119K—	$0—	$0—
Total	$49.32M-1.3%	$49.96M—	——	——
Available for sale investments	$49.39M-1.4%	$50.08M—	——	——
Cash And Cash Equivalents And Short Term Investments Amortized Cost	$232.37M-16.4%	$277.81M-18.3%	$340.21M-32.8%	$506.56M—
Cash, cash equivalents and investments, fair value	$232.43M-16.4%	$277.92M-18.3%	$340.12M—	——
Commodity Contract Asset Current	$3.86M—	——	——	——
Common stock, capital shares reserved for future issuance	$716K+17.2%	$611K+13.4%	$539K+6.3%	$507K+42.8%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M+100%	$100M0.0%	$100M0.0%	$100M0.0%
Common stock, shares issued (in shares)	$60.63M+3.0%	$58.88M+2.3%	$57.56M+1.8%	$56.52M+14.2%
Common Stock, Shares, Outstanding	$60.63M+3.0%	$58.88M+2.3%	$57.56M+1.8%	$56.52M+14.2%
Contract with Customer, Asset, after Allowance for Credit Loss	$3.86M+89.9%	$2.03M-27.5%	$2.8M-17.6%	$3.4M—
Contract with Customer, Liability	$6.88M+223%	$2.13M-29.0%	$3M-14.3%	$3.5M—
Finite-Lived Intangible Assets, Accumulated Amortization	$4.48M-71.7%	$15.79M+35.6%	$11.65M+82.2%	$6.39M+367%
Gross Carrying Amount	$17.9M-72.9%	$66.13M0.0%	$66.13M0.0%	$66.13M+237%
Insurance receivable for litigation settlement costs	——	——	——	——
Insurance receivable for litigation settlement costs	$0—	——	——	——
Raw materials	$20.19M+16.6%	$17.32M-35.9%	$27.02M-6.1%	$28.79M+53.3%
Lessee Operating Lease Liability Payments Due	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
Remainder of fiscal 2026	——	——	——	——
Liabilities Related to Investment Contracts, Fair Value Disclosure	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	——	——	——	——
Other current liabilities	$722K-24.9%	$961K+123%	$430K-52.6%	$908K-54.5%
Other (including finance leases)	$15M—	$0—	——	——
Prepaid expenses	$9.63M—	——	——	——
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Settlement Liabilities, Current	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$1.28M-32.6%	$1.89M-10.7%	$2.12M-13.6%	$2.45M-14.7%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$30.8+4.1%	$29.6+22.4%	$24.18-2.0%	$24.67+8.1%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$6.62M-82.5%	$37.84M+464%	$6.72M-79.9%	$33.45M-86.2%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Liability for issuance of shares of common stock	$0—	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——
Sublease Income - Thereafter	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Twist Bioscience Corporation.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Twist Bioscience Corporation's total assets?: Twist Bioscience Corporation (TWST) holds $676.2M in total assets, up 13.5% year over year.
How much debt does Twist Bioscience Corporation have?: Twist Bioscience Corporation carries $110.8M in total debt against $455.1M of shareholders' equity, a debt-to-equity ratio of 0.24.
How much cash does Twist Bioscience Corporation have?: Twist Bioscience Corporation holds $124.9M in cash and equivalents.
Can Twist Bioscience Corporation cover its short-term obligations?: Its current ratio is 2.70 — current assets exceed current liabilities.
Where does Twist Bioscience Corporation's balance sheet data come from?: Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.